Courtney A McKnight
Courtney A McKnight
Clinical Associate Professor of Epidemiology
-
Professional overview
-
Dr. Courtney McKnight is a Principal Investigator specializing in mixed methods research focused on the epidemiology of drug use, opioid overdose, HIV and HCV infection. Dr. McKnight has over 20 years of experience conducting public health research related to drug use, as well as field experience as a harm reduction service provider.
Prior to joining NYU, Dr. McKnight served as the assistant director of research at the Chemical Dependency Institute at the Icahn School of Medicine at Mount Sinai, where she was an investigator and project director on numerous federally funded research studies, including evaluations of syringe services programs; investigations of the drivers that contribute to disparate rates of HIV and HCV; and interventions to increase access to HIV and HCV testing and care.
Previous to Dr. McKnight’s work in research, she directed a harm reduction program for women who use drugs and volunteered at a syringe services program in New Jersey.
Dr. McKnight received her DrPH from the City University of New York Graduate Center, her Master of Public Health from Hunter College, and her Bachelor of Arts in sociology from Rutgers University. Her dissertation examined the impact of Medicaid coverage of methadone and buprenorphine on treatment access for opioid dependent beneficiaries.
Dr. McKnight’s current research interests include examining the shifting landscape of illicit opioids, including the increasing prevalence of illicitly manufactured fentanyl, and risk environments of people who use drugs.
-
Education
-
BA, Women's Studies, Rutgers University, New Brunswick, NJMPH, Community Health Education, Hunter College, New York, NYDrPH, The City University of New York, New York, NY
-
Areas of research and study
-
Behavioral ScienceDrug addictionEpidemiologyHarm reductionHepatitisHIV/AIDSInfectious DiseasesMixed-Methods ResearchOpioidQualitative ResearchSocial epidemiologySubstance Abuse
-
Publications
Publications
Is your syringe services program cost-saving to society? A methodological case study
Failed retrieving data.Is your syringe services program cost-saving to society? A methodological case study
Failed retrieving data.Hepatitis C incidence and prevalence among Puerto Rican people who use drugs in New York City
Failed retrieving data.Toward the Interpretation of Positive Testing for Fentanyl and Its Analogs in Real Hair Samples : Preliminary Considerations
Failed retrieving data.Alternative kinship structures, resilience and social support among immigrant trans Latinas in the USA
Failed retrieving data.Geographic distribution of risk ("Hotspots") for HIV, HCV, and drug overdose among persons who use drugs in New York City : The importance of local history
Failed retrieving data.Geographic distribution of risk ("Hotspots") for HIV, HCV, and drug overdose among persons who use drugs in New York City: the importance of local history
Failed retrieving data.Injection and Heterosexual Risk Behaviors for HIV Infection Among Non-gay Identifying Men Who Have Sex with Men and Women
Failed retrieving data.Prescription opiate analgesics, heroin, HIV and HCV among persons who inject drugs in New York City, 2016-2018
Failed retrieving data.Prescription opiate analgesics, heroin, HIV and HCV among persons who inject drugs in New York City, 2016-2018
Failed retrieving data.Being “hooked up” during a sharp increase in the availability of illicitly manufactured fentanyl : Adaptations of drug using practices among people who use drugs (PWUD) in New York City
Failed retrieving data.Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs
Failed retrieving data.Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000–2017 : Protective effects of non-injecting drug use
Failed retrieving data.Heterosexual male and female disparities in HIV infection at the end of an epidemic : HIV infection among persons who inject drugs in New York City, 2001–2005 and 2011–2015
Failed retrieving data.Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York city, 2011-2015, with implications for the current opioid epidemic in the US
Failed retrieving data.Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US
Failed retrieving data.Decline in herpes simplex virus type 2 among non-injecting heroin and cocaine users in New York City, 2005 to 2014 : Prospects for avoiding a resurgence of human immunodeficiency virus
Failed retrieving data.Decline in HSV-2 among non-injecting Heroin and Cocaine users in New York City, 2005-2014: potential protection against HIV resurgence
Failed retrieving data.Perceived discrimination among racial and ethnic minority drug users and the association with health care utilization
Failed retrieving data.Racial/ethnic disparities at the end of an HIV epidemic : Persons who inject drugs in New York City, 2011-2015
Failed retrieving data.Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City : Implications for prevention
Failed retrieving data.Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention
Failed retrieving data.The New York 911 Good Samaritan Law and Opioid Overdose Prevention Among People Who Inject Drugs
Failed retrieving data.What happened to the HIV epidemic among non-injecting drug users in New York City?
Failed retrieving data.Consistent estimates of very low HIV incidence among people who inject drugs : New York City, 2005-2014
Failed retrieving data.